scispace - formally typeset
Patent

Quinazoline derivatives as angiogenesis inhibitors

Reads0
Chats0
TLDR
In this paper, the use of compounds of formula (I), wherein ring C is an 8, 9, 10, 12 or 13-membered bicyclic or tricyclic moiety which optionally may contain 1-3 heteroatoms selected independently from O, N and S, was discussed.
Abstract
The invention relates to the use of compounds of formula (I), wherein ring C is an 8, 9, 10, 12 or 13-membered bicyclic or tricyclic moiety which optionally may contain 1-3 heteroatoms selected independently from O, N and S; Z is -O-, -NH-, -S-, -CH2- or a direct bond; n is 0-5; m is 0-3; R2 represents hydrogen, hydroxy, halogeno, cyano, nitro, trifluoromethyl, C?1-3?alkyl, C1-3alkoxy, C1-3alkylsulphanyl, -NR?3R4? (wherein R?3 and R4?, which may be the same or different, each represents hydrogen or C?1-3?alkyl), or R?5X1?- (wherein X?1 and R5? are as defined herein; R1 represents hydrogen, oxo, halogeno, hydroxy, C?1-4?alkoxy, C1-4alkyl, C1-4alkoxymethyl, C1-4alkanoyl, C1-4haloalkyl, cyano, amino, C2-5alkenyl, C2-5alkynyl, C1-3alkanoyloxy, nitro, C1-4alkanoylamino, C1-4alkoxycarbonyl, C1-4alkylsulphanyl, C1-4alkylsulphinyl, C1-4alkylsulphonyl, carbamoyl, N-C1-4alkylcarbamoyl, N,N-di(C1-4alkyl)carbamoyl, aminosulphonyl, N-C1-4alkylaminosulphonyl, N,N-di(C1-4alkyl)aminosulphonyl, N-(C1-4alkylsulphonyl)amino, N-(C1-4alkylsulphonyl)-N-(C1-4alkyl)amino, N,N-di(C1-4alkylsulphonyl)amino, a C3-7alkylene chain joined to two ring C carbon atoms, C1-4alkanoylaminoC1-4alkyl, carboxy or a group R?56X10? (wherein X?10 and R56? are as defined herein); and salts thereof, in the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals, processes for the preparation of such compounds, pharmaceutical compositions containing a compound of formula (I) or a pharmaceutically acceptable salt thereof as active ingredient and compounds of formula (I). The compounds of formula (I) and the pharmaceutically acceptable salts thereof inhibit the effects of VEGF, a property of value in the treatment of a number of disease states including cancer and rheumatoid arthritis.

read more

Citations
More filters
Patent

Targeted binding agents against b7-h1

TL;DR: Human monoclonal antibodies directed against B7-H1 and uses of these antibodies in diagnostics and for the treatment of diseases associated with the activity and/or expression of B7H1 are disclosed in this article.
Patent

Quinazoline derivatives as VEGF inhibitors

TL;DR: In this paper, the quinazoline derivatives of formula (I) were defined, where m is an integer from 1 to 3; R 1 represents halogeno or C?1-3?alkyl; X?1? represents -O-; R 2 is selected from one of the following three groups: 1) piperidin-4-yl, C?2-5?alkynylR?3? (wherein R 3 is as defined hereinbefore); and salts thereof; processes for their preparation, pharmaceutical compositions containing a compound of
Patent

c-Met modulators and methods of use

TL;DR: In this article, the authors provide compounds for modifying protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion.
References
More filters
Book

Molecular Cloning: A Laboratory Manual

TL;DR: Molecular Cloning has served as the foundation of technical expertise in labs worldwide for 30 years as mentioned in this paper and has been so popular, or so influential, that no other manual has been more widely used and influential.
Book

Baculovirus expression vectors: a laboratory manual.

TL;DR: This laboratory manual simplifies selection of the most appropriate baculovirus vector design for a given problem by describing each step of the implementation process - from vector construction to large-scale protein production.
PatentDOI

Tyrosine kinase inhibitors

TL;DR: In this article, the imidazo[1,2-a]pyrimidine derivatives are used for treating cellular proliferative diseases, for treating disorders associated with MET activity, and for inhibiting the receptor tyrosine kinase MET.
Patent

Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase

TL;DR: In this article, a method of inhibiting abnormal cell proliferation in a patient suffering from a disorder characterized by such proliferation comprising the administration of an EGF and/or PDGF receptor inhibiting effective amount of said bis mono-and/or bicyclic aryl/or heteroaryl compound and their preparation of said compounds and their use in pharmaceutical compositions used in this method.
Patent

Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors

TL;DR: Substituted heteroaromatic compounds are protein tyrosine kinase inhibitors as discussed by the authors, in which one ring is a pyridine or pyrimidine of formula (I).
Related Papers (5)